Cargando…
Targeting histone deacetylases: perspectives for epigenetic-based therapy in cardio-cerebrovascular disease
Although the pathogenesis of cardio-cerebrovascular disease (CCVD) is multifactorial, an increasing number of experimental and clinical studies have highlighted the importance of histone deacetylase (HDAC)-mediated epigenetic processes in the development of cardio-cerebrovascular injury. HDACs are a...
Autores principales: | Wang, Zi-Ying, Qin, Wen, Yi, Fan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394331/ https://www.ncbi.nlm.nih.gov/pubmed/25870619 http://dx.doi.org/10.11909/j.issn.1671-5411.2015.02.010 |
Ejemplares similares
-
Histone Deacetylases as Epigenetic Targets for Treating Parkinson’s Disease
por: Li, Yan, et al.
Publicado: (2022) -
Histone deacetylase 10, a potential epigenetic target for therapy
por: Cheng, Fajuan, et al.
Publicado: (2021) -
Interleukin-6: A Novel Target for Cardio-Cerebrovascular Diseases
por: Su, Jian-Hui, et al.
Publicado: (2021) -
Editorial: Bioactive substances-mediated targeted therapy of cardio-cerebrovascular diseases
por: Tong, Xiaoyong, et al.
Publicado: (2023) -
Epigenetic Targeting of Histone Deacetylases in Diagnostics and Treatment of Depression
por: Park, Hyun-Sun, et al.
Publicado: (2021)